Onabotulinumtoxin A is under clinical development by AbbVie and currently in Phase III for Unspecified Musculoskeletal Disorders.

All eyes in Kansas City have been on Patrick Mahomes' left ankle this week. After a productive week at practice, it appears coach Andy Reid has seen enough to convince him that his star ...

Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, announced that Health Canada approved Xeomin (incobotulinumtoxinA) for the treatment of post-stroke lower limb ...

The Kansas City Chiefs quarterback, who left during a win over the Cleveland Browns early last week and was later diagnosed with a “mild” high ankle sprain, was a full participant in practice ...

“This approval means that adult patients who have suffered from a stroke and are experiencing lower limb spasticity in the ankle and foot will now have a safe and effective treatment option ...

BURLINGTON, Ontario, December 17, 2024--(BUSINESS WIRE)--Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, today announced that Health Canada approved XEOMIN ...

"This approval means that adult patients who have suffered from a stroke and are experiencing lower limb spasticity in the ankle and foot will now have a safe and effective treatment option," explains ...

For a more permanent fix, my dentist suggested I try 'masseter Botox', to target the muscle rather than treat the symptoms. But what actually is it, does it work, and how long does the treatment last?

Mahomes left Sunday's game in the fourth quarter, later getting ruled questionable to return with an ankle injury but ultimately remaining sidelined for the rest of the contest. Early reports ...